Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBF Conditioning for Refractory/Relapsed Aggressive B-cell NHL
NCT01786018Phase 2Unknown
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Feb 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, busulfan, fludarabine in B-cell non-Hodgkin lymphoma, sponsored by AOU Città della Salute e della Scienza di Torino. Status: unknown.
02
Drugs
thiotepabusulfanfludarabine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01786018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786018.